G. Bakris

1.0k total citations
15 papers, 604 citations indexed

About

G. Bakris is a scholar working on Cardiology and Cardiovascular Medicine, Nephrology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, G. Bakris has authored 15 papers receiving a total of 604 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cardiology and Cardiovascular Medicine, 5 papers in Nephrology and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in G. Bakris's work include Diabetes Treatment and Management (5 papers), Blood Pressure and Hypertension Studies (4 papers) and Chronic Kidney Disease and Diabetes (3 papers). G. Bakris is often cited by papers focused on Diabetes Treatment and Management (5 papers), Blood Pressure and Hypertension Studies (4 papers) and Chronic Kidney Disease and Diabetes (3 papers). G. Bakris collaborates with scholars based in United States, Spain and Australia. G. Bakris's co-authors include J.C. Burnett, A. Osama Gaber, Gary Meininger, Dennis K. Yue, Joel Jiang, Elias David‐Neto, Javier Nieto Guevara, Keith Usiskin, Bertrand Cariou and Ga‐Lai Law and has published in prestigious journals such as Kidney International, Journal of the American Society of Nephrology and European Heart Journal.

In The Last Decade

G. Bakris

15 papers receiving 581 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
G. Bakris United States	7	314	279	122	119	115	15	604
Hanneke Buter Netherlands	11	134 0.4×	108 0.4×	227 1.9×	146 1.2×	93 0.8×	29	544
Allan B. Schwartz United States	15	150 0.5×	83 0.3×	308 2.5×	115 1.0×	170 1.5×	36	773
Henrik Post Hansen Denmark	16	417 1.3×	260 0.9×	334 2.7×	89 0.7×	75 0.7×	35	900
François C. Reubi Switzerland	14	258 0.8×	276 1.0×	357 2.9×	139 1.2×	172 1.5×	15	864
Stylianos Panagoutsos Greece	14	254 0.8×	67 0.2×	129 1.1×	106 0.9×	45 0.4×	49	544
Anne B. Gould United States	11	228 0.7×	146 0.5×	269 2.2×	108 0.9×	153 1.3×	23	722
Athanasios Roumeliotis Greece	14	293 0.9×	74 0.3×	86 0.7×	102 0.9×	64 0.6×	41	572
Nitin Khosla United States	9	265 0.8×	257 0.9×	328 2.7×	64 0.5×	106 0.9×	14	637
Jay H. Stein United States	12	244 0.8×	29 0.1×	59 0.5×	86 0.7×	174 1.5×	16	583
Vincent Spagnoli France	8	214 0.7×	22 0.1×	197 1.6×	118 1.0×	78 0.7×	17	541

Countries citing papers authored by G. Bakris

Since Specialization

Citations

This map shows the geographic impact of G. Bakris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Bakris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Bakris more than expected).

Fields of papers citing papers by G. Bakris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Bakris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Bakris. The network helps show where G. Bakris may publish in the future.

Co-authorship network of co-authors of G. Bakris

This figure shows the co-authorship network connecting the top 25 collaborators of G. Bakris. A scholar is included among the top collaborators of G. Bakris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Bakris. G. Bakris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Mahaffey, Kenneth W., Florian M.M. Baeres, G. Bakris, et al.. (2022). Baseline cardiovascular risk in subjects with type 2 diabetes and chronic kidney disease from the FLOW trial. European Heart Journal. 43(Supplement_2). 1 indexed citations

Agarwal, Rajiv, Bertram Pitt, Peter Rossing, et al.. (2022). In patients with type 2 diabetes chronic kidney disease is a modifiable cardiovascular risk factor. European Heart Journal. 43(Supplement_2). 2 indexed citations

Jardine, Meg, Zien Zhou, Hiddo J.L. Heerspink, et al.. (2020). SAT-156 RENAL, CARDIOVASCULAR, AND SAFETY OUTCOMES OF CANAGLIFLOZIN ACCORDING TO BASELINE ALBUMINURIA: A CREDENCE SECONDARY ANALYSIS. Kidney International Reports. 5(3). S67–S67. 1 indexed citations

Agarwal, Rupesh, James Baldassarre, G. Bakris, et al.. (2019). Evaluating the Effects of Canagliflozin on Cardiovascular and Renal Events in Patients with Type 2 Diabetes and Chronic Kidney Disease According to Baseline HbA1c, Including Those with HbA1c <7%: Results From the CREDENCE Trial. 10 indexed citations

Wheeler, DC, Rajiv Agarwal, G. Bakris, et al.. (2018). The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) study rationale and design. UCL Discovery (University College London). 3 indexed citations

Parati, Gianfranco, E. Agabiti Rosei, G. Bakris, et al.. (2017). [PP.12.09] MASKED-UNCONTROLLED HYPERTENSION MANAGEMENT BASED ON OFFICE BP OR ON OUT-OF-OFFICE (AMBULATORY) BP MEASUREMENT (MASTER). Journal of Hypertension. 35(Supplement 2). e190–e190. 1 indexed citations

Kario, Kazuomi, G. Bakris, & Deepak L. Bhatt. (2015). 4A.10. Journal of Hypertension. 33(Supplement 1). e52–e52. 2 indexed citations

Yale, J.‐F., G. Bakris, Bertrand Cariou, et al.. (2014). Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes mellitus and chronic kidney disease. Diabetes Obesity and Metabolism. 16(10). 1016–1027. 224 indexed citations

Bakris, G., Luís M. Ruilope, Francesco Locatelli, et al.. (2007). Treatment of microalbuminuria in hypertensive subjects with elevated cardiovascular risk: Results of the IMPROVE trial. Kidney International. 72(7). 879–885. 76 indexed citations

10.

Stafylas, Panagiotis, Pantelis Sarafidis, Anastasios N. Lasaridis, et al.. (2007). Cost-effectiveness of losartan in diabetic nephropathy: a Greek perspective. Journal of Nephrology. 20(6). 703–715. 6 indexed citations

11.

Bakris, G., et al.. (1995). Renal effects of oral prostaglandin supplementation after ibuprofen in diabetic subjects. Journal of the American Society of Nephrology. 5(9). 1684–1688. 17 indexed citations

12.

Bakris, G., et al.. (1991). Exfoliative dermatitis secondary to tobramycin sulfate.. PubMed. 47(5). 331–2. 3 indexed citations

13.

Bakris, G., et al.. (1990). Radiocontrast medium-induced declines in renal function: a role for oxygen free radicals. American Journal of Physiology-Renal Physiology. 258(1). F115–F120. 236 indexed citations

14.

Bakris, G., et al.. (1989). Renal dysfunction resulting from NSAIDs.. PubMed. 40(4). 199–204. 14 indexed citations

15.

Bakris, G., et al.. (1983). Disopyramide-Associated Liver Dysfunction. Mayo Clinic Proceedings. 58(4). 265–267. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact